IL121432A - Pyrrolo [3,2-C]azepine-4-one derivatives and pyrrolo [3,4-C]azepine-4-one derivatives their preparation and pharmaceutical compositions containing them - Google Patents

Pyrrolo [3,2-C]azepine-4-one derivatives and pyrrolo [3,4-C]azepine-4-one derivatives their preparation and pharmaceutical compositions containing them

Info

Publication number: IL121432A
Authority: IL; Israel
Prior art keywords: alkyl; chem; group; azepine; pyrrolo
Prior art date: 1995-12-01

Application number

IL12143296A

Other languages

English (en)

Other versions

IL121432A0 (en

Original Assignee

Suntory Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-12-01

Filing date

1996-12-02

Publication date

2000-09-28

1996-12-02 Application filed by Suntory Ltd filed Critical Suntory Ltd

1998-01-04 Publication of IL121432A0 publication Critical patent/IL121432A0/xx

2000-09-28 Publication of IL121432A publication Critical patent/IL121432A/xx

Links

OAZDMYPWBNYDFR-UHFFFAOYSA-N 5h-pyrrolo[3,4-c]azepin-4-one Chemical class O=C1NC=CC=C2C=NC=C12 OAZDMYPWBNYDFR-UHFFFAOYSA-N 0.000 title 1
BUYGQJHBXQPBHG-UHFFFAOYSA-N N1=CC=C2C(NC=CC=C21)=O Chemical class N1=CC=C2C(NC=CC=C21)=O BUYGQJHBXQPBHG-UHFFFAOYSA-N 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 6
125000004450 alkenylene group Chemical group 0.000 abstract 2
125000002947 alkylene group Chemical group 0.000 abstract 2
125000003710 aryl alkyl group Chemical group 0.000 abstract 2
CTVOZUFKICZROL-UHFFFAOYSA-N pyrrolo[3,2-b]azepine Chemical class C1=CC=CC2=NC=CC2=N1 CTVOZUFKICZROL-UHFFFAOYSA-N 0.000 abstract 2
102000056834 5-HT2 Serotonin Receptors Human genes 0.000 abstract 1
108091005479 5-HT2 receptors Proteins 0.000 abstract 1
DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 abstract 1
125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 abstract 1
125000004419 alkynylene group Chemical group 0.000 abstract 1
230000003042 antagnostic effect Effects 0.000 abstract 1
125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 1
150000004945 aromatic hydrocarbons Chemical class 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
231100000053 low toxicity Toxicity 0.000 abstract 1
208000031225 myocardial ischemia Diseases 0.000 abstract 1
230000002093 peripheral effect Effects 0.000 abstract 1
125000000168 pyrrolyl group Chemical group 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 abstract 1
125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Diabetes (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IL12143296A 1995-12-01 1996-12-02 Pyrrolo [3,2-C]azepine-4-one derivatives and pyrrolo [3,4-C]azepine-4-one derivatives their preparation and pharmaceutical compositions containing them IL121432A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP33571495		1995-12-01
JP4692896		1996-02-09
PCT/JP1996/003522 WO1997020845A1 (fr)	1995-12-01	1996-12-02	Derives de pyrroloazepine

Publications (2)

Publication Number	Publication Date
IL121432A0 IL121432A0 (en)	1998-01-04
IL121432A true IL121432A (en)	2000-09-28

Family

ID=26387089

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL12143296A IL121432A (en)	1995-12-01	1996-12-02	Pyrrolo [3,2-C]azepine-4-one derivatives and pyrrolo [3,4-C]azepine-4-one derivatives their preparation and pharmaceutical compositions containing them

Country Status (12)

Country	Link
US (4)	US5962448A (de)
EP (1)	EP0807632B1 (de)
JP (1)	JP3563076B2 (de)
KR (1)	KR19980701788A (de)
AT (1)	ATE216388T1 (de)
AU (1)	AU719230B2 (de)
CA (1)	CA2212092A1 (de)
DE (1)	DE69620745T2 (de)
ES (1)	ES2179218T3 (de)
HU (1)	HUP9900672A3 (de)
IL (1)	IL121432A (de)
WO (1)	WO1997020845A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU719230B2 (en)	1995-12-01	2000-05-04	Daiichi Suntory Pharma Co., Ltd	Pyrroloazepine derivatives
JPH10251258A (ja) *	1997-03-14	1998-09-22	Suntory Ltd	ピロロアゼピン系化合物
JPH11193290A (ja)	1997-12-26	1999-07-21	Suntory Ltd	ピロールスルホンアミド系化合物
JPH11193289A (ja) *	1997-12-26	1999-07-21	Suntory Ltd	ピロールスルホンアミド誘導体
ATE269704T1 (de) *	1999-02-17	2004-07-15	Daiichi Suntory Pharma Co Ltd	Pyrroloazepinderivate enthaltende arzneimittel zur behandlung von claudicatio intermittens
ATE260916T1 (de) *	1999-12-16	2004-03-15	Daiichi Suntory Pharma Co Ltd	Verfahren zur herstellung von optisch aktiven pyrroloazepinderivaten
FR3008975A1 (fr)	2013-07-23	2015-01-30	Servier Lab	Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
IL283725B2 (en)	2017-06-20	2024-04-01	Imbria Pharmaceuticals Inc	Compositions and methods for increasing efficiency of cardiac metabolism
KR102822532B1 (ko) *	2018-07-23	2025-06-19	스미토모 파마 가부시키가이샤	축환 락탐 유도체
EP3866794B1 (de)	2018-10-17	2024-12-04	Imbria Pharmaceuticals, Inc.	Verfahren zur behandlung von rheumatischen erkrankungen unter verwendung von trimetazidinbasierten verbindungen
EP3976101A4 (de)	2019-05-31	2023-06-21	Imbria Pharmaceuticals, Inc.	Verfahren zur behandlung von fibrose unter verwendung von verbindungen zur förderung der glucoseoxidation
US11530184B2 (en)	2020-06-30	2022-12-20	Imbria Pharmaceuticals, Inc.	Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11780811B2 (en)	2020-06-30	2023-10-10	Imbria Pharmaceuticals, Inc.	Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11883396B2 (en)	2021-05-03	2024-01-30	Imbria Pharmaceuticals, Inc.	Methods of treating kidney conditions using modified forms of trimetazidine
CN113788777B (zh) *	2021-09-07	2023-04-11	华中科技大学	一种制备1-取代-3-羰基吡咯的方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2419119A (en) *	1943-07-02	1947-04-15	Westinghouse Electric Corp	Apparatus for treating and storing meat
US2545491A (en) *	1945-10-25	1951-03-20	American Instr Co Inc	Apparatus for precision control of climatic conditions
US2825680A (en) *	1953-03-31	1958-03-04	Niagara Blower Co	Apparatus for concentrating aqueous solutions of hygroscopic organic substances
US3424231A (en) *	1967-03-23	1969-01-28	Andrew Truhan	Environmental chamber
US3415313A (en) *	1967-06-12	1968-12-10	Niagara Blower Co	Apparatus for producing air at widely different temperatures and relative humidities
US3671273A (en) *	1968-05-20	1972-06-20	Alec C Gunter	Apparatus for preparing a cocoa concentrate
US3617699A (en) *	1969-03-10	1971-11-02	Donald F Othmer	A system for electrically heating a fluid being transported in a pipe
US4103508A (en) *	1977-02-04	1978-08-01	Apple Hugh C	Method and apparatus for conditioning air
FR2578842B1 (fr)	1985-03-15	1987-04-10	Rhone Poulenc Sante	Nouveaux derives de la pyrrolo(1,2-a) azepinone, leur preparation et les compositions pharmaceutiques qui les contiennent
JPS62161786A (ja) *	1986-01-08	1987-07-17	Mitsubishi Chem Ind Ltd	ピロ−ル化合物
US4769998A (en) *	1986-04-25	1988-09-13	Advantage Electronics, Incorporated	Precision-controlled water chiller
KR970005300B1 (ko) *	1987-09-03	1997-04-15	글락소 그룹 리미티드	락탐 유도체
DE68926553T2 (de) *	1988-08-02	1996-10-17	Glaxo Group Ltd., London	Lactamderivate
JP3198117B2 (ja) *	1990-02-07	2001-08-13	サントリー株式会社	ピロロアゼピン誘導体
JPH0525128A (ja) *	1990-05-11	1993-02-02	Suntory Ltd	ピロロアゼピン誘導体の製造方法
ES2196000T3 (es) *	1991-08-07	2003-12-16	Daiichi Suntory Pharma Co Ltd	Compuesto de pirroloazepina.
AU655841B2 (en) *	1991-08-07	1995-01-12	Daiichi Suntory Pharma Co., Ltd	Pyrroloazepine derivative
US5544275A (en) *	1993-03-17	1996-08-06	Applied Materials, Inc.	Electrically heated fluid carrying conduit having integrated heating elements and electrical conductors
JP3714685B2 (ja) *	1994-05-18	2005-11-09	第一サントリーファーマ株式会社	ハイメニアルディシン及びその誘導体並びにそれらの合成中間体の製造法並びにその合成中間体
CA2189297C (en) *	1995-11-02	2004-09-21	Masahiro Imoto	Process for preparing 1-substituted pyrrole-3-carboxylic acid derivatives
AU719230B2 (en)	1995-12-01	2000-05-04	Daiichi Suntory Pharma Co., Ltd	Pyrroloazepine derivatives
JPH10251258A (ja)	1997-03-14	1998-09-22	Suntory Ltd	ピロロアゼピン系化合物
JPH11193289A (ja)	1997-12-26	1999-07-21	Suntory Ltd	ピロールスルホンアミド誘導体

1996
- 1996-12-02 AU AU76558/96A patent/AU719230B2/en not_active Ceased
- 1996-12-02 HU HU9900672A patent/HUP9900672A3/hu unknown
- 1996-12-02 ES ES96939340T patent/ES2179218T3/es not_active Expired - Lifetime
- 1996-12-02 CA CA002212092A patent/CA2212092A1/en not_active Abandoned
- 1996-12-02 EP EP96939340A patent/EP0807632B1/de not_active Expired - Lifetime
- 1996-12-02 AT AT96939340T patent/ATE216388T1/de active
- 1996-12-02 DE DE69620745T patent/DE69620745T2/de not_active Expired - Fee Related
- 1996-12-02 IL IL12143296A patent/IL121432A/xx not_active IP Right Cessation
- 1996-12-02 US US08/875,495 patent/US5962448A/en not_active Expired - Fee Related
- 1996-12-02 WO PCT/JP1996/003522 patent/WO1997020845A1/ja not_active Ceased
- 1996-12-02 KR KR1019970705185A patent/KR19980701788A/ko not_active Abandoned
- 1996-12-02 JP JP52115297A patent/JP3563076B2/ja not_active Expired - Fee Related
1999
- 1999-05-17 US US09/312,713 patent/US6258805B1/en not_active Expired - Fee Related
2001
- 2001-03-09 US US09/801,816 patent/US6489473B2/en not_active Expired - Fee Related
2002
- 2002-07-03 US US10/188,234 patent/US6713634B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
HUP9900672A3 (en)	2001-11-28
ES2179218T3 (es)	2003-01-16
US6489473B2 (en)	2002-12-03
US5962448A (en)	1999-10-05
HUP9900672A2 (hu)	1999-06-28
EP0807632B1 (de)	2002-04-17
IL121432A0 (en)	1998-01-04
EP0807632A1 (de)	1997-11-19
KR19980701788A (ko)	1998-06-25
US20030166926A1 (en)	2003-09-04
US6258805B1 (en)	2001-07-10
WO1997020845A1 (fr)	1997-06-12
AU719230B2 (en)	2000-05-04
US20020072515A1 (en)	2002-06-13
DE69620745D1 (de)	2002-05-23
AU7655896A (en)	1997-06-27
JP3563076B2 (ja)	2004-09-08
EP0807632A4 (de)	1998-12-09
CA2212092A1 (en)	1997-06-12
ATE216388T1 (de)	2002-05-15
US6713634B2 (en)	2004-03-30
DE69620745T2 (de)	2002-10-31

Legal Events

Date	Code	Title
2001-06-14	KB	Patent renewed
2003-02-12	KB	Patent renewed
2004-02-08	HP	Change in proprietorship
2007-07-24	MM9K	Patent not in force due to non-payment of renewal fees

Publication	Publication Date	Title
IL121432A (en)	2000-09-28	Pyrrolo [3,2-C]azepine-4-one derivatives and pyrrolo [3,4-C]azepine-4-one derivatives their preparation and pharmaceutical compositions containing them
HUT70035A (en)	1995-09-28	Condensed imidazo pyridine derivatives, pharmaceutical preparations containing them and process for their preparation
AU2344988A (en)	1989-04-06	Piperidine-tetra hydrofurane or tetra hydrothiophene spiro derivatives and methods for their preparation
AU8345491A (en)	1992-04-02	Heterocyclic derivatives
NO990227L (no)	1995-03-02	Heterocykliske forbindelser som farmas°ytika
EP1070710A3 (de)	2001-03-21	Dithiolan Derivate, deren Herstellung und deren therapeutischer Wirkung
CA2030519A1 (en)	1990-09-24	Acryloyl substituted pyrrole derivatives
MA21693A1 (fr)	1990-07-01	Procede pour l'obtention de nouveaux composes.
EP0371805A3 (de)	1991-07-31	Piperidin-Derivate und diese enthaltende Hypotensiva
WO1994019343A3 (en)	1994-10-27	Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof
HRP931292B1 (en)	1999-08-31	Carbazolone derivatives and the process for preparing the same
PE25998A1 (es)	1998-05-19	DERIVADOS DE OCTAHIDRO-PIRROLO(1,2-a)-PIRAZINA 2,7-SUSTITUIDOS
WO1999033840A3 (en)	1999-09-10	Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha1-blocking action
DE69129165D1 (de)	1998-05-07	Prozess zur Darstellung von Lactamderivaten
DE69001111D1 (de)	1993-04-22	Antikrebs-zusammensetzung.
HU895422D0 (en)	1990-01-28	Process for the preparation of 1,4-diazabicyclo [3.2.2] nonane derivatives
CA2093631A1 (en)	1993-02-08	Pyrroloazepine derivative
KR920004392A (ko)	1992-03-27	플루오로에틸캄프토테신 유도체
DE68922053D1 (de)	1995-05-11	Pyridoindolderivate und Verfahren zu ihrer Herstellung.
AU7529287A (en)	1988-01-14	Pristinamycin process
NO982282L (no)	1998-07-20	Synergistisk immunsuppresjonspreparat inneholdende en 2,2'-bi-1H-pyrrolforbindelse
CA2168514A1 (en)	1996-09-11	Isocarbacyclin derivatives
ES8705413A1 (es)	1987-05-01	Un procedimiento para preparar derivados de benzopirano.
CA2053705A1 (en)	1992-04-20	Piperazine derivatives
ES2087173T3 (es)	1996-07-16	Uso de derivados de piridoindol en el tratamiento de enfermedades isquemicas.